MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Cytokine Profiles as Biomarkers for Neurodegenerative Diseases: An inflammatory study on Parkinson’s Disease and Tauopathies

    A. Jäck, W. Wilfert, C. Palleis, A. Bernhardt, E. Weidinger, S. Katzdobler, U. Fietzek, D. Teupser, J. Levin (Munich, Germany)

    Objective: To investigate the diagnostic and prognostic value of cytokine profiles in cerebrospinal fluid (CSF) and serum of patients with Parkinson's Disease (PD), Progressive Supranuclear…
  • 2024 International Congress

    Plasma Biomarkers of Alzheimer’s Pathology Identify Prodromal Dementia with Lewy bodies

    A. Delva, A. Pelletier, E. Sommerville, J. Montplaisir, J. Gagnon, G. Kollmorgen, T. Kam-Thong, T. Kustermann, V. Machado, Z. Gan-Or, R. Postuma (Montreal, Canada)

    Objective: To determine whether plasma biomarkers of Alzheimer’s disease (AD) pathology can predict phenoconversion from idiopathic/isolated REM sleep behavior disorder (iRBD) to dementia with Lewy…
  • 2024 International Congress

    Assessing the Accuracy of Clinical Diagnostic Criteria of Lewy Body Dementia for Detection of Lewy Body Disease in the Oldest-Old: The 90+ Study

    R. Rajmohan, Z. Al-Darsani, N. Phielipp, T. Montine, M. Corrada, C. Kawas (Orange, USA)

    Objective: To examine if Lewy Body dementia (LBD) clinical diagnostic criteria will be less accurate for detecting Lewy Body Disease (the pathological diagnosis) in the oldest-old…
  • 2024 International Congress

    Age-associated presbyvestibulopathy is more severely abnormal in PD compared to the older controls

    N. Bohnen, G. Carli, T. Brown, S. David, J. Barr, R. Vangel, T. Johnson, K. Kerber, D. Mccaslin (Ann Arbor, USA)

    Objective: We aim to investigate differences in specific vestibular tests between individuals diagnosed with Parkinson’s Disease (PD) and elderly healthy controls. With consideration for potential…
  • 2024 International Congress

    Focused Ultrasound Therapy Treatment for Parkinson’s Disease

    Z. Muttalib, B. Syed, M. Alam, D. Nadora, U. Ansari, R. Sedighi, A. Vemulapalli, S. Asad (Elk Grove, USA)

    Objective: Parkinson’s Disease is a neurodegenerative disease that mainly affects the substantia nigra and nigrostriatal pathway and leads to rigidity, loss of muscle tone, tremors,…
  • 2024 International Congress

    Influence of immigration on Parkinson’s disease: analysis of clinical presentation.

    A. Peral Quirós, N. Caballol Pons, A. Planas Ballvé, M. Balagué Marmaña, MI. Gómez Ruiz, A. ávila Rivera (Barcelona, Spain)

    Objective: To analyze the epidemiological and clinical presentation in our immigrants patients with Parkinson’s disease (PD) from our reference population in Barcelona, Spain. Background: In…
  • 2024 International Congress

    Immune cell traits and Parkinson’s disease: A Mendelian randomization study

    JL. Wang, Y. Fang, YL. Li, R. Zheng, Y. Chen, J. Tian, XZ. Yin, JL. Pu, BR. Zhang (Hangzhou, China)

    Objective: To examine the causal link between peripheral immune cell traits and Parkinson's disease (PD) risk. Background: Observational studies have highlighted an association between peripheral…
  • 2024 International Congress

    PKG-Ethnicity project: An initial analysis of ethnical differences in Parkinson’s KinetoGraph (PKG) results between white and non-white ethnic groups

    MA. Qamar, L. Batzu, D. Trivedi, K. Ray Chaudhuri (London, United Kingdom)

    Objective: Using the Parkinson’s KinetiGraph (PKG) reports of PwP to determine if scores vary according to ethnicity, classed as white or non-white PwP (Black, Asian,…
  • 2024 International Congress

    Exploring the Prevalence of Subjective Cognitive Decline and Mild Cognitive Impairment in Participants of the Luxembourg Healthy Ageing Study

    S. Jónsdóttir, C. Pauly, V. Schröder, O. Tsurkalenko, T. Marques, C. Horlings, A. Garrido, C. Vega, S. Schade, P. Mahlknecht, C. Gomes, S. Ghosh, K. Rege, R. Rawal, D. Mcintyre, K. Seppi, M. Martí, C. Trenkwalder, E. Tolosa, W. Poewe, V. Satagopam, B. Mollenhauer, R. Krüger (Heisdorf, Luxembourg)

    Objective: Determine prevalence of Subjective Cognitive Decline(SCD) and Mild Cognitive Impairment(MCI) in participants of the Luxembourg Healthy Ageing(HeBA) Study. Background: Cognitive impairment can present as…
  • 2024 International Congress

    Predicting cognitive phenotypes in de novo Parkinson’s disease: an fMRI data-driven approach.

    MI. de Bartolo, A. Ojha, G. Leodori, C. Piervincenzi, G. Vivacqua, S. Pietracupa, M. Costanzo, F. D'Antonio, S. Barbetti, R. Margiotta, G. Bruno, A. Conte, A. Berardelli, G. Fabbrini, P. Pantano, D. Belvisi (Rome, Italy)

    Objective: To verify whether connectivity changes in the dorsolateral prefrontal cortex (DLPC) and the precuneus (PCun) can predict cognitive phenotypes in de novo Parkinson’s disease…
  • « Previous Page
  • 1
  • …
  • 60
  • 61
  • 62
  • 63
  • 64
  • …
  • 181
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley